Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Mini Oral session - Sarcoma

VEGFR2 Polymorphisms as Novel Biomarker of Anti-angiogenic Therapy for Pediatric and Young Adult Sarcoma

Date

22 Nov 2019

Session

Mini Oral session - Sarcoma

Topics

Tumour Site

Bone Sarcomas;  Soft Tissue Sarcomas

Presenters

Qiyuan Bao

Citation

Annals of Oncology (2019) 30 (suppl_9): ix135-ix139. 10.1093/annonc/mdz433

Authors

Q. Bao, Y. Hu, J. Wen, Y. Shen, W. Zhang

Author affiliations

  • Bone Oncology, ruijin hospital, 020 - shanghai/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.